The White House’s Office of Science Technology and Policy (OSTP) this week sought input from any and all biotech stakeholders on the innovation, products, technology and data derived from biologically-related processes and science that drive economic growth, promote health and increase public benefit. Referred to as the “Bioeconomy,” OSTP said it’s seeking comments before October 23rd from the public, including those with capital investments, those performing research or developing enabling platforms and applications in the field of biological sciences, including healthcare, medicine, pharmaceuticals, biotechnology and manufacturing. Submitted comments should be limited to 10 pages or less. Learn More